ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
Food and Chemical Toxicology
Volume 45, Issue 3, March 2007, Pages 486-493
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (458 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.fct.2006.09.012    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier Ltd All rights reserved.

Effects of lotus plumule supplementation before and following systemic administration of lipopolysaccharide on the splenocyte responses of BALB/c mice

Jin-Yuarn LinCorresponding Author Contact Information, a, E-mail The Corresponding Author, Ying-Shu Laia, Chien-Jung Liua and Ann-Ru Wua

aDepartment of Food Science and Biotechnology, National Chung Hsing University, 250 Kuokuang Road, Taichung 40227, Taiwan, ROC

Received 29 September 2005; 
accepted 20 September 2006. 
Available online 1 October 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

To determine whether lotus plumule supplementation alleviates acute systemic inflammation in vivo, the BALB/c mice were continuously supplemented with lotus plumule for 3 weeks, following administration with an intraperitoneal (i.p.) injection of lipopolysaccharide (LPS) at a concentration of 10 mg/kg body weight (BW) to induce acute systemic inflammation. At 24 h after injection of LPS, the mice were sacrificed and the visceral organ weight and splenocyte responses were measured. The results showed that lotus plumule supplementation did not significantly affect body weights and IL-6 secretion of splenocyte cultures from BALB/c mice. LPS challenge significantly increased the relative organ weights of the lungs, liver, and spleen, however low dose supplementation (40 mg/kg BW/day) with lotus plumule significantly decreased the relative organ weights of the inflammatory liver, spleen and kidney. Low dose supplementation with lotus plumule significantly increased IL-10 production of splenocyte cultures, however high dose supplementation (800 mg/kg BW/day) significantly decreased IL-10 production. These results suggest that low dose and 3-week supplementation of lotus plumule might alleviate acute systemic inflammation in vivo via decreasing the visceral organ inflammation and increasing the production of anti-inflammatory cytokine IL-10 from splenocytes. These results are valuable for developing future nutraceuticals and anti-inflammatory agents from traditional medicinal foods.

Keywords: Lotus plumule; Lipopolysaccharide; IL-6; IL-10; Splenocytes; BALB/c mice

Article Outline

1. Introduction
2. Materials and methods
2.1. Sample preparation
2.2. Experimental animals and dietary groups
2.3. Challenge with LPS by intraperitoneal (i.p.) injection to induce systemic inflammation in a female BALB/c mouse model
2.4. Sample collection and analytical methods
2.4.1. Tissue collection and analysis
2.4.2. Preparation of splenocyte cultures
2.4.3. Splenocyte proliferation stimulated by lotus plumule in vivo
2.4.4. Measurement of cytokine and inflammatory mediator levels secreted by splenocyte cultures by an enzyme-linked immunosorbent assay (ELISA)
2.4.4.1. IL-6, and IL-10 levels in splenocyte cultures
2.4.4.2. Nitric oxide (NO) levels in splenocyte cultures
2.5. Statistical analysis
3. Results
3.1. Effects of lotus plumule supplementation on body and visceral organ weights of LPS-challenged mice
3.2. Effects of lotus plumule supplementation on splenocyte proliferation of LPS-challenged mice
3.3. Effects of lotus plumule supplementation on the levels of cytokines and pro-inflammatory mediators from LPS-challenged mice
4. Discussion
5. Conclusion
Acknowledgements
References





 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.